David E. Lazar - 26 Jul 2023 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Chief Executive Officer, Director
Signature
/s/ David E. Lazar
Issuer symbol
TTNP
Transactions as of
26 Jul 2023
Net transactions value
$0
Form type
4
Filing time
31 Jul 2023, 19:39:50 UTC
Previous filing
28 Jun 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Award $0 +100,000 $0.000000 100,000 26 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.